Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variants of SARS CoV-2: mutations, transmissibility, virulence, drug resistance, and antibody/vaccine sensitivity.

Frontiers in bioscience (Landmark edition) - 14 Feb 2022

Prüβ Birgit M

Abstract excerpt

Severe acute respiratory syndrom coronavirus-2 (SARS CoV-2) is the causative agent of coronavirus disease-19 (Covid-19) which has been designated a worldwide pandemic by the World Health Organization on March 11, 2020. Since that time, the virus has mutated and an assortment of variants have been successful at establishing themselves in the human population. This review article describes the SARS CoV-2 genome,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to COVID-19
Share to Drug Resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to SARS-CoV-2

Share to SARS-CoV-2 and COVID-19 Research

Share to Vaccines

Share to Virulence

Source

Identifiers

PMID: 35227008
DOI: 10.31083/j.fbl2702065

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variants of SARS CoV-2: mutations, transmissibility, virulence, drug resistance, and antibody/vaccine sensitivity.PMID 35227008Read ↗

The Development of SARS-CoV-2 Variants: The Gene Makes the DiseaseSemantic proximity Read ↗

Novel SARS-CoV-2 variants: the pandemics within the pandemic.Semantic proximity Read ↗

Covid-19: virology, variants, and vaccinesSemantic proximity Read ↗

Mutations in the genome of severe acute respiratory syndrome coronavirus 2: implications for COVID-19 severity and progression.Semantic proximity Read ↗

SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and VaccinesSemantic proximity Read ↗

Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike MutationsSemantic proximity Read ↗

Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine developmentSemantic proximity Read ↗

The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance.Semantic proximity Read ↗

Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine EffectivenessSemantic proximity Read ↗

Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions.Semantic proximity Read ↗

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.Semantic proximity Read ↗

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.